112 related articles for article (PubMed ID: 8837061)
21. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
[TBL] [Abstract][Full Text] [Related]
22. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
[TBL] [Abstract][Full Text] [Related]
23. [MCNU delivery into malignant brain tumor and normal brain tissue by intravenous or intraarterial infusion].
Miyagami M; Tazoe M; Tsubokawa T
Gan To Kagaku Ryoho; 1990 Feb; 17(2):275-80. PubMed ID: 2154161
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
[TBL] [Abstract][Full Text] [Related]
25. Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors.
Liu Y; Hashizume K; Chen Z; Samoto K; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Jun; 23(4):379-87. PubMed ID: 11428519
[TBL] [Abstract][Full Text] [Related]
26. Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.
Kroll RA; Pagel MA; Muldoon LL; Roman-Goldstein S; Fiamengo SA; Neuwelt EA
Neurosurgery; 1998 Oct; 43(4):879-86; discussion 886-9. PubMed ID: 9766316
[TBL] [Abstract][Full Text] [Related]
27. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma.
Nakashima M; Shibata S; Tokunaga Y; Fujita H; Anda T; Arizono K; Tomiyama N; Sasaki H; Ichikawa M
J Pharm Pharmacol; 1997 Aug; 49(8):777-80. PubMed ID: 9379355
[TBL] [Abstract][Full Text] [Related]
28. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.
Oldfield EH; Clark WC; Dedrick RL; Egorin MJ; Austin HA; DeVroom HD; Joyce KM; Doppman JL
Cancer Res; 1987 Apr; 47(7):1962-7. PubMed ID: 3815385
[TBL] [Abstract][Full Text] [Related]
29. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
30. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.
Ningaraj NS; Rao M; Hashizume K; Asotra K; Black KL
J Pharmacol Exp Ther; 2002 Jun; 301(3):838-51. PubMed ID: 12023511
[TBL] [Abstract][Full Text] [Related]
31. Modified immunoregulation associated with interferon-gamma treatment of rat glioma.
Oshiro S; Liu Y; Fukushima T; Asotra K; Black KL
Neurol Res; 2001 Jun; 23(4):359-66. PubMed ID: 11428516
[TBL] [Abstract][Full Text] [Related]
32. The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas.
Nakagawa H; Groothuis D; Blasberg RG
Neurology; 1984 Dec; 34(12):1571-81. PubMed ID: 6504329
[TBL] [Abstract][Full Text] [Related]
33. Retro-inverso bradykinin opens the door of blood-brain tumor barrier for nanocarriers in glioma treatment.
Xie Z; Shen Q; Xie C; Lu W; Peng C; Wei X; Li X; Su B; Gao C; Liu M
Cancer Lett; 2015 Dec; 369(1):144-51. PubMed ID: 26282786
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin.
Xia CY; Zhang Z; Xue YX; Wang P; Liu YH
J Neurooncol; 2009 Aug; 94(1):41-50. PubMed ID: 19234812
[TBL] [Abstract][Full Text] [Related]
35. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas.
Black KL; Cloughesy T; Huang SC; Gobin YP; Zhou Y; Grous J; Nelson G; Farahani K; Hoh CK; Phelps M
J Neurosurg; 1997 Apr; 86(4):603-9. PubMed ID: 9120622
[TBL] [Abstract][Full Text] [Related]
36. Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
Bartus RT; Snodgrass P; Marsh J; Agostino M; Perkins A; Emerich DF
J Pharmacol Exp Ther; 2000 Jun; 293(3):903-11. PubMed ID: 10869391
[TBL] [Abstract][Full Text] [Related]
37. Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7).
Barth RF; Yang W; Bartus RT; Moeschberger ML; Goodman JH
Neurosurgery; 1999 Feb; 44(2):351-9; discussion 359-60. PubMed ID: 9932889
[TBL] [Abstract][Full Text] [Related]
38. Leukotriene E4 selectively increase the delivery of methotrexate to the C6 gliomas in rats.
Chio CC; Lin SJ; Lin MT
J Neurooncol; 1995; 25(2):89-95. PubMed ID: 8543974
[TBL] [Abstract][Full Text] [Related]
39. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
[TBL] [Abstract][Full Text] [Related]
40. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.
Zhang H; Gu YT; Xue YX
Brain Res; 2007 May; 1144():33-41. PubMed ID: 17331483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
